APAX Medical Introduces Cutting-Edge ADVATx Laser For Skin Rejuvenation

March 06, 2024 01:22 PM CET | By Cision
 APAX Medical Introduces Cutting-Edge ADVATx Laser For Skin Rejuvenation
Image source: Kalkine Media

SINGAPORE, March 6, 2024 /PRNewswire/ -- APAX Medical & Aesthetics Clinic is proud to announce the introduction of the ADVATx laser treatment by Advalight in their offerings - a revolutionary laser system that targets both active acne and acne scars simultaneously. This innovative solution utilises two laser wavelengths, offering a unique and comprehensive approach to dermatological care. Set to launch on 1 March 2024, the Advalight treatment is a game-changer for individuals seeking advanced and effective acne and acne scar removal treatment in Singapore.

The ADVATx laser treatment sets itself apart by addressing the dual challenge of active acne and acne scars in a single procedure. By targeting inflammation, sebaceous glands, and acne scars concurrently, this cutting-edge therapy provides a more holistic solution compared to traditional approaches. Not only does it excel in acne management, post acne redness, pigmentation and scarring, but it also extends its efficacy to treat conditions like rosacea, melasma, red or hypertrophic scars, and broken capillaries.

Acknowledging the challenges associated with acne relapse, APAX Medical & Aesthetics Clinic emphasises the importance of maintenance therapy with topical retinoids. Early intervention is crucial to preventing potential scarring and enhancing the overall quality of life for patients. The ADVATx laser treatment aligns with APAX Medical's commitment to comprehensive skincare, addressing challenges head-on to deliver optimal results.

Studies have found that acne scarring affects up to 95% of patients with acne, and is severe in 30% of cases, leading to long-term effects like poor self-esteem, anxiety, depression, and social impairment, emphasising the importance of treating active acne and acne scars concurrently to reduce disease burden and potential scarring. Recognising this need, ADVATx laser treatment is APAX Medical's latest addition to an impressive portfolio of services. APAX Medical's commitment to advancing skincare solutions, including treatment for cystic acne, acne scars, hormonal acne, back acne and more, is reflected in its history of delivering exceptional results and building a diverse client portfolio.

APAX Medical's unveiling of the ADVATx laser treatment marks a significant milestone in the management of acne and acne scars. With a rich history of excellence, APAX Medical & Aesthetics Clinic addresses acne comprehensively and aims to position itself as a leader in providing cutting-edge solutions for skincare.

For further information or inquiries, please visit https://apaxmedical.com/.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

Sponsored Articles